IPP Bureau
Briefs: Shivalik Rasayan and Dr. Reddy's Laboratories
By IPP Bureau - July 20, 2023
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
Sandoz plans to build a Biosimilar Technical Development Center in Slovenia
By IPP Bureau - July 20, 2023
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
Healthcare Triangle awarded contract expansion with Fortune 500 biopharmaceutical customer
By IPP Bureau - July 20, 2023
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Novartis acquires DTx Pharma to develop siRNA therapies
By IPP Bureau - July 19, 2023
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
SEBI approves Piramal Pharma’s Rs 1,050-crore rights issue
By IPP Bureau - July 19, 2023
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
PrecisionLife identifies first detailed genetic risk factors for long COVID
By IPP Bureau - July 19, 2023
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Helping Hand Foundation launches screening for glaucoma in Hyderabad
By IPP Bureau - July 19, 2023
First of its kind screening for Glaucoma at grass root level over 10k screened already
Strand Life Sciences expands sequencing facility
By IPP Bureau - July 19, 2023
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
Dr Reddys Laboratories signs for consumption of renewable energy
By IPP Bureau - July 18, 2023
Lonza launches new cell culture media system TheraPRO
By IPP Bureau - July 18, 2023
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
PredOmix, Core Diagnostics partner to launch OncoVeryx-F
By IPP Bureau - July 18, 2023
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
JeNaCell launches wound dressing epicite balance for chronic wounds
By IPP Bureau - July 17, 2023
Moist wound dressing for chronic wound treatment now available in Germany
Evonik and Heraeus cooperate to expand the range of services for highly potent API
By IPP Bureau - July 17, 2023
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
CARER collaborates with Wholeleaf to enhance holistic cancer care services
By IPP Bureau - July 17, 2023
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
